Advanced company searchLink opens in new window

TYMPA HEALTH TECHNOLOGIES LIMITED

Company number 11029091

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
02 Sep 2024 TM01 Termination of appointment of Mark Nicholas John Poole as a director on 25 July 2024
25 Jun 2024 AA Total exemption full accounts made up to 31 December 2023
08 Mar 2024 SH01 Statement of capital following an allotment of shares on 12 February 2024
  • GBP 2,359.7029
18 Jan 2024 AP01 Appointment of Mr Steve Cashman as a director on 19 December 2023
17 Jan 2024 CS01 Confirmation statement made on 4 January 2024 with updates
09 Nov 2023 SH01 Statement of capital following an allotment of shares on 2 November 2023
  • GBP 2,205.3615
18 Oct 2023 SH08 Change of share class name or designation
13 Oct 2023 AP01 Appointment of Mr Matthieu Vallin as a director on 6 July 2023
06 Oct 2023 TM01 Termination of appointment of Richard Joseph Stringer as a director on 6 October 2023
29 Sep 2023 AA Total exemption full accounts made up to 31 December 2022
08 Mar 2023 RP04SH01 Second filing of a statement of capital following an allotment of shares on 13 February 2023
  • GBP 2,203.9817
28 Feb 2023 SH08 Change of share class name or designation
28 Feb 2023 SH08 Change of share class name or designation
24 Feb 2023 SH01 Statement of capital following an allotment of shares on 13 February 2023
  • GBP 2,203.9817
  • ANNOTATION Clarification a second filed SH01 was registered on 08/03/2023.
24 Feb 2023 SH01 Statement of capital following an allotment of shares on 10 February 2023
  • GBP 2,105.8735
24 Feb 2023 MA Memorandum and Articles of Association
24 Feb 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
22 Feb 2023 PSC08 Notification of a person with significant control statement
22 Feb 2023 PSC07 Cessation of Mark Nicholas John Poole as a person with significant control on 16 February 2023
22 Feb 2023 AP01 Appointment of Mr Richard Joseph Stringer as a director on 10 February 2023
17 Jan 2023 CS01 Confirmation statement made on 4 January 2023 with updates
11 Jan 2023 PSC07 Cessation of Savram Krishan Ramdoo as a person with significant control on 21 May 2018
11 Jan 2023 PSC01 Notification of Mark Nicholas John Poole as a person with significant control on 4 March 2019
09 Nov 2022 AD01 Registered office address changed from Office 402 - Spaces, 4th Floor Jubilee House 213 Oxford Street London W1D 2LF England to Landmark 33 Cavendish Square London W1G 0PW on 9 November 2022
28 Oct 2022 SH01 Statement of capital following an allotment of shares on 27 October 2022
  • GBP 1,613.8689